Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Start Codon
Cambridge, England, UK
- Ownership
- Private
- Development stage
- Other
01
Overview
Start Codon does not develop therapeutics directly, but accelerates and invests in a diversified cohort of early-stage companies in life sciences and healthcare, including those advancing first-in-class therapeutics, diagnostics, medtech, and digital health solutions. Success is evaluated by the companies' ability to secure Series A funding and enter later stages of clinical and commercial development.
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugateRNA therapyGene therapyDeviceDiagnosticDigital health
- Industry
- Investors
02
Partnerships
Cambridge Innovation CapitalBabraham Bioscience TechnologiesGenentech (member of Roche Group)Milner Therapeutics Institute
Beyond the preview
Go deeper on Start Codon.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Start Codon.